glp-1 colorectal cancer death risk study november 2025 drugs linked to dramatically lower rates in colon patients Long-term cancer risk in users

Autoimmune considerations : There is no evidence that GLP-1 receptor agonists worsen autoimmune thyroid disease or trigger new-onset Hashimoto's thyroiditis

Livesey G, Taylor R, Livesey HF, Buyken AE, Jenkins DJA, Augustin LSA, et al

Such treatment, however, often failed, leaving patients with no option but to undergo surgery

This counts when obesity-related illnesses, such as type 2 diabetes, sleep apnea, or osteoarthritis, dictate decisions

Personalized programs like TrimRX offer the medical oversight needed to safely use GLP-1 medications, ensuring you stay on track and address any concerns that may arise

24 , 223232 (2007) Chatterjee, S., Ghosal, S